
The purpose of this study was to evaluate the cost effectiveness of colorectal cancer screening interventions with their effects on health disparity being considered.Markov cohort simulation was conducted with the cycle/duration of 1/40 year(s). Data came from the results of randomized trials and others. Participants were hypothetical cohorts aged 50 years as of year 2013 in 16 Korean provinces. The interventions until the age of 80 were annual organized fecal occult blood test (FOBT) (standard screening), annual FOBT with basic reminders for provinces with higher mortalities than the national average (targeted reminder) and annual FOBT with basic/enhanced reminders for all provinces (universal reminder 1 and 2). The comparison was non-screening, the outcome was quality-adjusted life years, and only medical costs for screening and treatment were considered from a societal perspective. The Atkinson incremental cost effectiveness ratio (Atkinson ICER), the incremental cost effectiveness ratio adjusted by the Atkinson Inequality Index, was used to evaluate the cost effectiveness of the four interventions with their impacts on regional health disparity being considered.Health disparity was smallest (or greatest) in non-screening (or the standard screening). The targeted reminder had smaller health disparity, and smaller Atkinson ICER with respect to standard screening, than did the universal reminder 1 and 2.The targeted reminder might be more cost effective than the universal reminders with their effects on health disparity being considered. This study helps to develop promotional effort for colorectal cancer screening with both the greatest cost effectiveness and the smallest health disparity.
330, Biopsy, Cost-Benefit Analysis, Early Detection of Cancer/economics*, Health Status Disparities*, Colorectal neoplasms, Colorectal Neoplasms/diagnosis*, Occult Blood*, Cohort Studies, Cost-Benefit Analysis*, Mass Screening/methods, Mass Screening/economics*, Humans, Mass Screening, Healthcare Disparities/economics, Healthcare Disparities, Early Detection of Cancer, Aged, Colorectal Neoplasms/pathology, Cost-benefit analysis, Colonoscopy/economics, Mass screening, Colonoscopy, Health Status Disparities, Middle Aged, Markov Chains, Colorectal Neoplasms/economics, Socioeconomic Factors, Colorectal Neoplasms/therapy, Occult Blood, Health status disparities, Original Article, Quality-Adjusted Life Years, Early Detection of Cancer/methods, Colorectal Neoplasms
330, Biopsy, Cost-Benefit Analysis, Early Detection of Cancer/economics*, Health Status Disparities*, Colorectal neoplasms, Colorectal Neoplasms/diagnosis*, Occult Blood*, Cohort Studies, Cost-Benefit Analysis*, Mass Screening/methods, Mass Screening/economics*, Humans, Mass Screening, Healthcare Disparities/economics, Healthcare Disparities, Early Detection of Cancer, Aged, Colorectal Neoplasms/pathology, Cost-benefit analysis, Colonoscopy/economics, Mass screening, Colonoscopy, Health Status Disparities, Middle Aged, Markov Chains, Colorectal Neoplasms/economics, Socioeconomic Factors, Colorectal Neoplasms/therapy, Occult Blood, Health status disparities, Original Article, Quality-Adjusted Life Years, Early Detection of Cancer/methods, Colorectal Neoplasms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
